---
title: What are Gastrointestinal Cancers?
description: Learn about gastrointestinal cancers in dogs, including types like carcinomas and GISTs, symptoms, and treatment options. Discover how early detection and targeted therapies can improve outcomes and quality of life for your pet.
image: https://blog.fidocure.com/hubfs/Blog_Gastrointestinal%20Cancers.png
---
[](https://www.fidocure.com/)
- [Veterinarians](https://fidocure.com/for-veterinarians/)
- [Portal Login](https://dvm.fidocure.com/)
- [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
- [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
- [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)
# What are Gastrointestinal Cancers?
[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure)
[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers)
Gastrointestinal (GI) tumors in dogs are relatively rare but can be serious when they occur. These tumors affect the stomach, intestines, or other parts of the digestive system, and they can include various types such as gastrointestinal carcinomas, gastrointestinal stromal tumors (GIST), and leiomyosarcoma. While these tumors may cause symptoms like vomiting, weight loss, or changes in appetite, their treatment and prognosis depend on the type and stage of the tumor.
### **Types of Gastrointestinal Tumors**
- **Gastrointestinal carcinomas** are cancers that arise from the lining of the GI tract. They are typically aggressive and can metastasize (spread) to other parts of the body. Carcinomas can occur in the stomach, intestines, or rectum.
- **Gastrointestinal Stromal Tumors (GIST):** These tumors develop from the cells in the GI tract that support the structure of the tissues. GISTs are often slow-growing, but they can become large and cause obstructions in the digestive tract.
- **Leiomyosarcoma:** This type of cancer arises from the smooth muscle cells of the GI tract. Although less common, leiomyosarcoma can be aggressive and has the potential to metastasize.
### **Treatment Options for Gastrointestinal Tumors**
The treatment for GI tumors depends largely on the type of tumor, its location, and whether it has spread. Surgery is often the first-line treatment, especially if the tumor is localized and operable. Complete surgical removal of the tumor may be possible, offering a chance of cure in some cases. For more advanced tumors, surgery may be combined with other treatments like chemotherapy or targeted therapies.
- **Surgery:** This is typically the best option for removing localized tumors. Early detection of GI tumors significantly increases the chances of successful surgical removal.
- **Chemotherapy:** For cases where the tumor has spread or cannot be completely removed, chemotherapy may be recommended. Drugs like doxorubicin or carboplatin are used to slow the growth and spread of the tumor. However, chemotherapy is often more palliative, aiming to extend life and improve quality of life rather than cure the cancer.
- **Targeted Therapies:** As research progresses, targeted therapies are becoming more prominent in veterinary oncology. These treatments work by targeting specific mutations or proteins that drive tumor growth.
Key molecular targets in canine GI tumors include:
- **KIT in GIST**: Mutations in the KIT gene drive tumor growth. Targeted therapies like Palladia (toceranib phosphate) have been shown to be effective against GIST in dogs by blocking the mutated KIT protein.
- **EGFR in Carcinomas**: Some carcinomas overexpress EGFR. While not yet common in veterinary oncology, EGFR inhibitors show promise.
### **Emerging Options and Genetic Testing**
Genetic testing, like those offered by FidoCure, can provide critical insights into the specific mutations driving a dog’s cancer. This allows for more personalized treatment options, including targeted therapies based on the dog’s tumor profile. With the identification of mutations like KIT, EGFR, and PDGFR, therapies can be selected to more effectively inhibit tumor growth.
### **Prognosis**
The prognosis for dogs with gastrointestinal tumors depends on the type, size, and stage of the tumor at diagnosis. For tumors caught early and treated aggressively, dogs can experience significant extensions in life expectancy and quality of life. While some tumors are more aggressive, advancements in targeted therapies and precision medicine are providing new hope for dogs diagnosed with these cancers.
Pet owners should work closely with their veterinarian or veterinary oncologist to explore the latest diagnostic and treatment options, including the potential for genetic testing and targeted therapies. Services like FidoCure can help identify actionable genetic mutations and recommend treatments that might offer a better outcome for dogs with gastrointestinal tumors.
## Related Articles
[%20(5).png)](https://blog.fidocure.com/fidocure-blog/interview-with-dr.-len-lichtenfeld-former-chief-medical-officer-of-american-cancer-society)
[Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
### [Fireside Chat with Dr. Len Lichtenfeld - Former Deputy Chief Medical Officer of American Cancer Society](https://blog.fidocure.com/fidocure-blog/interview-with-dr.-len-lichtenfeld-former-chief-medical-officer-of-american-cancer-society)
###### Exclusive fireside chat with a distinguished trio of cancer experts: Dr. Len Lichtenfeld former Deputy Chief Medical Officer for the American Cancer Society (and...
[Christina K. Lopes](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes)
[Read More](https://blog.fidocure.com/fidocure-blog/interview-with-dr.-len-lichtenfeld-former-chief-medical-officer-of-american-cancer-society)
[-1.png)](https://blog.fidocure.com/fidocure-blog/veterinaryoptimistpodcast)
### [Vet Optimist Podcast: Interview with CEO Christina K. Lopes and Jennifer Evans](https://blog.fidocure.com/fidocure-blog/veterinaryoptimistpodcast)
We are excited to share an inspiring and insightful episode of "The Veterinary Optimist" podcast, featuring our very own Christina Lopes, CEO and Co-Founder of The One...
[Christina K. Lopes](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes)
[Read More](https://blog.fidocure.com/fidocure-blog/veterinaryoptimistpodcast)
- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)
-
-
-
-
**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.
© Copyright 2018-2026 One Health Company, All rights reserved
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "FidoCure",
"url" : "https://blog.fidocure.com/fidocure-blog/author/fidocure"
},
"dateModified" : "2024-10-22T13:00:05.328Z",
"datePublished" : "2024-10-22T13:00:00.000Z",
"headline" : "What are Gastrointestinal Cancers?",
"image" : [ "https://blog.fidocure.com/hubfs/Blog_Gastrointestinal%20Cancers.png" ],
"mainEntityOfPage" : {
"@id" : "https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.fidocure.com/hubfs/fidocure_logo.png"
},
"name" : "FidoCure"
}
}
```